TMDX Stock Summary and Trading Ideas (Transmedics Group | NASDAQ:TMDX)

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

What symbol and exchange does Transmedics Group shares trade?

Transmedics Group trades on the NASDAQ stock market under the symbol TMDX.

What is Transmedics Group stock price doing today?

As of December 24, 2025, TMDX stock price declined to $126.99 with 269,922 million shares trading.

What is Transmedics Group's Beta?

TMDX has a beta of 0.73, meaning it tends to be less sensitive to market movements. TMDX has a correlation of 0.04 to the broad based SPY ETF.

How much is Transmedics Group worth?

TMDX has a market cap of $4.34 billion. This is considered a Mid Cap stock.

How much money does Transmedics Group make?

Last quarter Transmedics Group reported $144 million in Revenue and $.66 earnings per share. This fell short of revenue expectation by $-1 million and exceeded earnings estimates by $.30.

What is the highest and lowest price Transmedics Group traded in the last 3 year period?

In the last 3 years, TMDX traded as high as $177.37 and as low as $36.42.

What are the top ETFs holding Transmedics Group?

The top ETF exchange traded funds that TMDX belongs to (by Net Assets): IJR, VTI, VB, IWM, VBK.

Is Transmedics Group (TMDX) a good investment?

TMDX has outperformed the market in the last year with a return of +102.7%, while the SPY ETF gained +17.3%. In the last 3 month period, TMDX beat the market returning +5.4%, while SPY returned +4.4%. However, in the most recent 2 weeks TMDX has underperformed the stock market by returning -5.8%, while SPY returned +1.4%.

What are the support and resistance levels for Transmedics Group (TMDX)?

TMDX support price is $123.47 and resistance is $132.93 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TMDX shares will trade within this expected range on the day.